研究单位：[1]Hepatic Surgery Center,Tongji Hospital,Huazhong University of Science and Technology,Wuhan,Hubei,China,430030外科学系肝脏外科[2]Chinese Cooperative Group of Liver Cancer (CCGLC)[3]Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province[4]Haplox Biotechnology Co., Ltd.[5]Geneplus-Beijing Co. Ltd.[6]YuceBio Technology[7]Gelesis, Inc.
This registry is designed as a longitudinal cohort study of patients diagnosed with primary hepatobiliary cancer in Tongji Hospital, Wuhan. This study collects the clinical-pathological features of hepatic malignant tumors and the current status of patients who received comprehensive treatment based on surgical treatment since 1998.
